Home|Journals|Articles by Year|Audio Abstracts
 

Original Article



Down-regulation of Id1 and Id3 genes affects growth and survival of Human Umbilical Vein Endothelial Cells (HUVECs)

Foster Kyei, Du-Bois Asante, Juliet Ama Mawusi Edekor, Esther Sarpong, Edem Gavor, Daniels Konja.




Abstract
Cited by 4 Articles

Inhibitors of DNA (Id) proteins have been implicated in cell growth, cell cycle control, apoptosis and angiogenesis. Studies reveal that Id1 and Id3 may be required for angiogenesis in adult tissues. This work aimed at investigating the consequences of loss-of-function of Id protein on growth and apoptosis in an in vitro model using Human Umbilical Vein Endothelial Cells (HUVECs). Using automated image analysis software (CellProfiler Analyst), cell cycle profiles of cell populations following siRNA down-regulation of Id proteins were investigated. Also, cell viability analysis with 3-(4, 5-Dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay was evaluated. The study also employed flow cytometry using mitochondrial membrane-potential marker (3, 3’-Dihexyloxacarbocyanine Iodide) (DiOC6) and Propidium Iodide (PI) as a marker of non-viable necrotic cells. Down-regulation of Id1 and Id3 reduced viable HUVECs populations. In addition, knock down of Id1 and Id3 showed cell cycle arrest. Furthermore, cell death analysis following the silencing of Id1 and Id3 induced apoptosis. These findings suggest that the inhibition of Id1 and Id3 may impair endothelial cell activation and angiogenesis and may also provide an attractive target for the development of new therapies for angiogenic disorders.

Key words: Apoptosis, Angiogenesis, S-phase, Down-regulation, Human umbilical vein endothelial cells, Knock-down






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.